CRP and rheumatoid arthritis: Simultaneously, the average DAS28 score was also significantly reduced (p < 0.0001) from 6.77 to 4.48 in RA patients who were undergoing 6 months biologic therapy (Fig. 2b) whereas inflammation parameter including CRP did not drop significantly (p = 0.67) (Fig. 2c).